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Abstract
Background: Single-cell RNA sequencing is a powerful tool for characterizing cellular
heterogeneity in gene expression. However, high variability and a large number of zero
counts present challenges for analysis and interpretation. There is substantial
controversy over the origins and proper treatment of zeros and no consensus on
whether zero-inflated count distributions are necessary or even useful. While some
studies assume the existence of zero inflation due to technical artifacts and attempt to
impute the missing information, other recent studies argue that there is no zero
inflation in scRNA-seq data.
Results: We apply a Bayesian model selection approach to unambiguously
demonstrate zero inflation in multiple biologically realistic scRNA-seq datasets. We
show that the primary causes of zero inflation are not technical but rather biological in
nature. We also demonstrate that parameter estimates from the zero-inflated negative
binomial distribution are an unreliable indicator of zero inflation.
Conclusions: Despite the existence of zero inflation in scRNA-seq counts, we
recommend the generalized linear model with negative binomial count distribution,
not zero-inflated, as a suitable reference model for scRNA-seq analysis.
Keywords: Single-cell RNA sequencing, Zero inflation, Bayesian model selection, Cell
heterogeneity, Gene expression stochasticity

Single-cell RNA sequencing (scRNA-seq) is a powerful tool for studying the dynamics
of gene expression and for characterizing heterogeneity in complex mixtures of cells.
Technical advances, including unique molecular identifiers (UMIs) [1], combinatorial
barcoding [2, 3], and physical containment of cells in droplets [4, 5], have enabled profiling of ever larger numbers of cells with fewer RNA molecules sequenced per cell. The
sparseness of single-cell data presents challenges for analysis and interpretation. In particular, the high proportion of zero counts (zero inflation) that is observed for many genes
has become a major focus of discussion and debate. Zeros have variously been attributed
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to technical artifacts [6, 7] or to statistical sampling [8, 9]. Less attention has been given
to the biological factors that might contribute to zero inflation including the role of cellular heterogeneity. Substantial controversy has ensued over approaches for mitigating
potential bias rooted in zero inflation. In particular, numerous approaches have been proposed to replace observed zeros in count data with imputed non-zero values based on the
assumption that zeros are due to technical artifacts [10, 11]. On the other hand, several
recent studies use negative control data to demonstrate that the occurrence of zeros is
consistent with expectations from statistical sampling [8, 9] and implicate against imputation. In order to resolve these conflicting views, a principled examination of zeros in
biologically realistic scRNA-seq data is needed.
Statistical distributions describe the expected frequency of counts, including zeros,
under specific assumptions about the data generating process. If the frequency of a given
mRNA species is uniform across cells and variation from cell to cell is due only to independent statistical sampling, counts would follow a Poisson distribution. However, the
assumptions that give rise to the Poisson distribution are unrealistic due to numerous biological and technical factors that will cause mRNA to vary from cell to cell. As a result,
count data will be more variable than predicted by a Poisson distribution. The negative
binomial distribution provides a good approximation for the distribution of UMI count
data [12]. It assumes that the underlying mRNA frequencies are random and the excess
variability of observed counts is quantified by an overdispersion parameter, r. Count distributions can be extended to include a zero-inflated component that generates zeros at
random (with probability π0 ) regardless of the actual amount of mRNA present in a cell.
One can imagine that some of the counts that could have been non-zero are masked
and replaced by zeros. Zero-inflated Poisson (ZIP) and zero-inflated negative binomial
(ZINB) distributions are commonly used in this setting.
In addition to the count distribution, a statistical model of scRNA-seq data should
be able to incorporate explanatory variables to account for sex, cell type, or treatment
effects that are the focus of the experimental investigation as well as batch effects. Generalized linear models (GLMs) for count data are well-established statistical tools that
provide sophisticated modeling and inference capabilities using off-the-shelf software
[13–15]. GLMs are directly applicable to count data and do not require preprocessing such as scaling, normalization, or log-transformation with pseudo-counts. A GLM
developed for scRNA-seq data should include an adjustment (offset) that accounts for
cell-to-cell variation in the depth of sequencing. The offset effectively normalizes the
data with respect to variation in total UMI count per cell without directly altering the
data. In particular, the zero counts remain as zeros. The effect of including an offset
is to convert the scale of the GLM from a model of expected counts to a model of
expected rates of expression (μ) that is comparable across cells with different total UMI
counts.
Using the GLM framework, we apply a Bayesian model selection criterion [16] to
scRNA-seq data to identify the statistical distributions that best fit the data for each gene,
including zero and non-zero values. This is a more comprehensive evaluation of zero
inflation than previous studies that have relied solely on the comparison of the observed
versus expected proportion of zeros after model fitting [8, 9]. We consider the implications of statistical sampling, technical dropout, cell heterogeneity, and key biological
variables, and compare these to the observed data to better understand the statistical
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properties of zero inflation and to evaluate the impact of different modeling choices on
inference.
Typical droplet scRNA-seq experiments utilize UMI counts to quantify gene expression in single cells [1]. We center our analysis around data from a droplet scRNA-seq
experiment that shares characteristics common to many recent scRNA-seq experiments.
To generate these data, Skelly et al. [17] used 10X Chromium technology to profile cells
from the non-myocyte fraction of female and male mouse hearts. Cardiac non-myocytes,
which predominantly include leukocytes, vascular cells, and stromal cells, exhibit considerable transcriptional and cellular diversity. Like other recent scRNA-seq experiments,
these data include transcriptional profiles of thousands of cells (10,519) sequenced at a
relatively low per-cell depth (median 4270 UMIs) and display a high total fraction of zeros
(> 93%). The findings we report are general and are apparent in other scRNA-seq datasets.
In the Supplementary Materials (Additional file 1), we report the analysis of experimental data obtained from two additional biologically heterogeneous datasets, namely mouse
kidney [18] and human peripheral blood mononuclear cells [19].

Results
Why are there so many zeros?

The most important factor that determines the number of zeros in scRNA-seq data is
the sequencing depth (total UMI count) per cell. In the heart data, this ranges from 746
to 17,302 UMIs per cell after filtering to 5515 genes in order to remove genes with nonzero UMI counts in less than 10% of cells (Fig. 1a and Additional file 1: Fig. S1a and S1b).
Clearly, if the total UMI count in a cell is less than the number of genes, some genes will
have zero counts. Sequencing depth explains 95% of variation in the number of zeros per
cell (R2 = 0.945, p < 2.2e−16). While our focus here is on droplet-based scRNA-seq

Fig. 1 Factors that determine the number of zeros in scRNA-seq data. a Total UMI counts per cell, which
range from 746 to 17,302 with average 3819 UMIs per cell, are plotted against the number of zeros per cell.
Color coding indicates the individual cell types as determined by data-driven clustering. The proportion of
variance in the number of zeros that is explained by the total UMI count per cell (R2 = 0.947) was computed
based on fitting a loess regression to the data (blue curve). b The per-gene rates of expression (μg ), which
range from 0.23 to 97.4 with average 1.51 UMI/10K, are plotted against the number of zeros per gene. Genes
that were identified as zero-inflated by scRATE (1 SE) are indicated in dark blue
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which yields low total UMI counts on very large numbers of cells, the number of zeros is
also largely determined by read depth for single-cell sequencing platforms (e.g., Fluidigm
C1) that produce deeper coverage of smaller numbers of cells. For example, Bacher et al.’s
[20] datasets have R2 = 0.384. To account for variation in sequencing depth, we incorporate log of the total UMI count per cell as an offset in the generalized linear model (see the
“Methods” section). An offset can be thought of as a covariate for which the regression
parameter is fixed and not estimated. Hafemeister and Satija [21] have recently shown
that treating the offset as a covariate with an estimated coefficient leads to overfitting. The
effect of including an offset is simply to rescale the data from a count to a rate. In addition
to the overfitting problem, the use of a fixed regression coefficient provides a consistent
interpretation of the estimated model parameters as a rate of expression. For example, if
we set the offset to log(total UMI count per cell/10e5), the mean parameters from any of
the GLMs (P, NB, ZIP, or ZINB) can be interpreted as the expected gene-specific UMI
count per 10,000 total UMI.
The second most important factor in determining the number of zeros is the per-gene
average rate of expression. In the heart data, the rate of expression varies from 0.23 to
97.4 UMI/10K across 5515 genes (Fig. 1b and Additional file 1: Fig. S1c). In general, genes
with lower rates of expression will have a higher frequency of zeros. We compared the
expected number zeros for each gene, assuming a Poisson model with matching genespecific rates of expression and cell-specific offsets, to the observed numbers of zeros in
the heart data (Additional file 1: Fig. S1d). We see that many genes have “extra” zeros, in
some cases with thousands of zeros over expectation. Presumably, these genes have count
distributions that are overdispersed (NB), zero-inflated (ZIP), or both (ZINB).
Model selection can identify genes exhibiting zero inflation

In order to identify genes with zero inflation, we implemented a Bayesian model selection criterion—the expected log predictive density (ELPD) [16]—in our software package,
scRATE (https://github.com/churchill-lab/scRATE). The ELPD score estimates out-ofsample predictive accuracy of four statistical models (P, ZIP, NB, or ZINB). It penalizes
both underfitted and overfitted models. It examines all of the data, including non-zero
counts, to provide a more complete evaluation of the count distributions than approaches
that focus only on the zeros [8, 9]. scRATE uses leave-one-out cross-validation, which
provides a standard error (SE) to quantify uncertainty in the estimated ELPD scores.
The four models being compared have varying levels of complexity (P≺NB, P≺ZIP,
NB≺ZINB, and ZIP≺ZINB), and in order to ensure that a more complex model is selected
only when the ELPD is substantially better, we require that the difference in ELPD
between two models is greater than zero by a multiple of the SE (e.g., 0 SE, 1 SE, 2 SE, or
3 SE). In addition to the model selection criterion, scRATE reports Bayesian parameter
estimation and it can be used as a replacement for or as a complementary analysis tool
along with standard GLM software.
To evaluate the true positive and false positive rates for detecting zero-inflated (ZI)
genes—genes for which either the ZIP or ZINB model is selected—we simulated data
similar to the heart data but with fixed levels of zero inflation (
π0 ) ranging from 0 to
90% and depth of sequencing at 10,000 UMIs/cell (Simulation I in the “Methods” section
and Additional file 1: Fig. S2a). We applied scRATE to the simulated data using the 0,
1, and 2 SE thresholds (Table 1). scRATE has a high false positive rate at 0 SE, but at
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Table 1 Error rates and power of scRATE classification
Sequencing depth

Threshold
0 SE

1 SE

2 SE

10k

0.2349±0.0695

0.0325±0.0174

0.0014±0.0016

50k

0.1837±0.0557

0.0206±0.0159

0.0009±0.0016

10k

0.8116±0.0365

0.6152±0.0312

0.4641±0.0160

50k

0.8955±0.0158

0.7934±0.0176

0.7062±0.0165

(a)

(b)

Estimated false positive (FP, type I error) and true positive (TP, power) classification rates estimated from simulated data at
average depth of 10,000 or 50,000 UMIs per cell. See Simulation II in the “Methods” section for details

the 1 SE threshold, the false positive error rate falls below 0.05, and at the 2 SE threshold, false positives are controlled at a stringency suitable for multiple testing across genes.
In addition, we simulated data with average sequencing depths up to 50,000 UMIs/cell—
higher than most droplet scRNA-seq data—and observed a substantial improvement in
power (Additional file 1: Fig. S2b). This suggests that deeper coverage may be beneficial
for detecting ZI genes. We carried out additional simulations to examine performance of
different thresholds as described in the “Methods” section (Simulation II) and Supplementary Materials (Additional file 1: Fig. S3). Having established that scRATE can detect
ZI genes in simulated data, we next applied our model selection criterion to the heart data.
scRNA-seq data are zero-inflated for some genes

Townes et al. [8] and Svensson [9] have shown that the P or NB models, without zero inflation, are sufficient to capture technical variability of scRNA-seq data. It is still of interest
to determine whether these models are flexible enough to also capture biological heterogeneity. In order to evaluate whether and how biological factors are contributing to zero
inflation, we initially analyzed the heart data without considering any associated biological knowledge. We applied scRATE to each of 5515 genes to classify them according
to their best fitting model (Table 2(a)) and to identify ZI genes. We found that for 1474
genes, the best model (0 SE) is one of the ZI options. Using more conservative thresholds,
we found 220 genes (1 SE), 76 genes (2 SE), or 35 genes (3 SE) were best fit by a ZI model.
In order to evaluate the extent of under-calling of ZI genes by scRATE, we first downsampled the data by randomly selecting subsets of cells and then repeated the model
selection analysis (Simulation III in the “Methods” section and Additional file 1: Fig. S4).
The number of ZI genes detected continues to increase with the number of cells even
up to 10,000 cells. This suggests that the number of ZI genes detected, especially at the
stringent 2 SE threshold, is an underestimate of the actual number of ZI genes. The ZI
genes detected at 2 SE represent a lower bound on the number of high-confidence ZI
genes that might be detected in a larger number of cells.
It seems intuitive that ZI genes would have a higher proportion of zeros and lower average expression when compared to other genes [6]. However, our findings support the
opposite conclusion (Fig. 2a and Additional file 1: Table S1). In our analysis of the heart
data, ZI genes often have a lower proportion of zeros and higher rates of expression compared to genes that are not ZI (Fig. 2b–d). In cells where ZI genes are expressed, they
exhibit higher average levels of expression compared to genes without zero inflation. The
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Table 2 scRATE classification of genes in the heart data
Threshold

Selected model
P

NB

ZIP

ZINB

0 SE

1111

2930

525

949

1 SE

2112

3183

81

139

2 SE

2930

2509

5

71

3 SE

3445

2035

1

34

0 SE

1523

2317

518

1105

1 SE

2733

2583

63

84

2 SE

3544

1913

3

3

3 SE

4000

1461

0

2

0 SE

1118

2745

478

1094

1 SE

2107

3108

88

132

2 SE

2930

2432

5

68

3 SE

3420

1981

1

33

(a)

(b)

(c)

Genes were classified as one of four count models (P, NB, ZIP, or ZINB) using four levels of stringency (0 SE, 1 SE, 2 SE, or 3 SE).
Table shows the number of genes in each category using a GLM with only the offset term to account for cell sequencing depth
(a), using a GLM that also includes cell type as an explanatory covariate (b), and using a GLM that includes offset as well as a
randomly shuffled cell type as a covariate (c). See Additional file 1: Tables S3 and S4 for the results with the mouse kidney and the
human PBMC datasets

proportion of zeros is on average higher for NB genes compared to ZINB genes. The statistical test for zero inflation will have best power in cases where the gene is not expressed
in some cell type(s), but when it is expressed, expression levels are high. When expression levels are low across all cell types, zero inflation is hard to distinguish from statistical
sampling from a non-zero-inflated distribution. As a result, genes that are declared to
be ZI using statistical testing are potentially biased toward higher levels of expression.
Nonetheless, the number of zeros alone is not a good indicator of zero inflation; rather,
one must consider the entire count distribution to establish that zero inflation is present.
Most zero-inflated genes are due to variable expression rates across cell types

Skelly et al. [17] classified each cell in the heart data into one of 12 cell types by data-driven
clustering and integration of previous biological knowledge. The annotated cell types are
heterogeneous and include cell types that are similar to one another (e.g., macrophages
and dendritic cells) and cell types that are very different (e.g., smooth muscle cells and
B cells). If zero inflation is primarily due to technical dropout, we would expect to see
zeros evenly distributed across cell types. When we examined the distribution of zeros
across cells in the ZI genes, we found that they tended to cluster within certain cell types
(Fig. 3). The rate of expression of a gene is a major factor driving the frequency of zeros,
and for many genes, the rate of expression varies widely across cell types. This suggests
that we should evaluate zero inflation after taking cell type-specific rates of expression
into account.
To account for biological variation in expression rates, we introduced cell type as an
explanatory variable in the GLM and recomputed the scRATE classification (Table 2(b)).
After accounting for cell type, the number of zero-inflated genes drops markedly. Of the
76 genes that were originally classified as zero-inflated using the 2 SE thresholds, 72 are
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Fig. 2 Classification of genes by scRATE using the threshold of 1 SE. a A density histogram shows the
model selection for genes by scRATE as a function of percent non-zero cells. The ZI genes are uniformly
distributed across the range, including genes with few zero counts. b Density histogram of scRATE
classification collapsed to show only the ZI versus NotZI genes across percentages of non-zero cells. c
Distribution of percent of cells with non-zero UMI counts for genes according to scRATE classification. d
Distribution of average expression levels of genes according to scRATE classification. Also see Additional
file 1: Fig. S12 for the results with the other (0, 2, and 3 SE) thresholds

no longer classified as ZI, 3 genes remain ZI (Xist, Rc3h2, Cir1), and 3 genes become ZI
after accounting cell type (Prnp, Folr2, Tax1bp2), and for one gene (Mmp2), the scRATE
algorithm failed to converge when cell type was included in the model. Genes that are
no longer ZI after accounting for cell type display variation in rates of expression across
cell types, such as Col1a2 which is expressed primarily in fibroblasts, or Ptpn18 which is
expressed primarily in immune cells (Additional file 1: Fig. S6).
In order to assess if this change in number of ZI genes was due to fitting the more
complex model, we shuffled the cell type labels and repeated the scRATE classification.
Results with the labels shuffled are similar to the scRATE classification without cell type
(Table 2 (c)), demonstrating that the reduction in detected ZI genes is not due to a loss of
power when including cell type as an explanatory variable.
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Fig. 3 Zeros cluster within specific cell types. A bi-clustered heatmap of ZI genes (1 SE) by cell type shows
that zeros occur more frequently in specific cell types. The color scale indicates the difference between the
cell type-specific proportion of zeros and the mean proportion of zeros across all cells regardless of type.
Light shading indicates cell types that have highest frequency of zero UMI counts. Dendrograms are shown
in Additional file 1: Fig. S5

While the majority of genes that were originally classified as ZI are no longer ZI after
accounting for cell type, there are a handful of genes that remain or become ZI. Among
them, Xist is an X chromosome silencing gene that is expected to be expressed only in
female cells (Additional file 1: Fig. S7). The heart data represent a mixture of female and
male cells. We were able to unambiguously classify 63% of cells in silico as female or male
in origin based on the presence of UMIs associated with female-specific Xist or with the Ychromosome gene Ddx3y. scRATE classifies Xist as a zero-inflated gene at all thresholds
up to 2 SE, but Ddx3y is classified as NB and is only classified as a ZI gene at 0 SE after
adjusting for cell type. After accounting for sex as an explanatory variable, in the subset
of cells where we could establish sex, these genes are no longer ZI.
We fit a ZINB model to all genes and compared the estimated proportion of zero inflaπ0 decreases.
tion (π0 ), with and without cell type in the GLM (Fig. 4a). For most genes, 
This is most evident among the genes that were classified as ZI before the adjustment and
are no longer ZI after. For genes that remain ZI after accounting for cell type, there is little
change in 
π0 . For a handful of genes, including those that become ZI only after accounting
π0 are consistent with expectations from the
for cell type, 
π0 increases. These changes in 
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Fig. 4 Effect of accounting for cell type on estimated zero inflation and overdispersion. a The scatterplot
shows estimated zero inflation 
π0 before and after including cell type in the GLM with ZINB error model. Color
coding indicates the ZI classification of genes (1 SE) before and after accounting for cell type. The red point
(ZI:ZI) at 0.3 on the diagonal is Xist. The light blue point (NotZI:NotZI) to the right is Ddx3y. b The scatterplot
shows the estimated overdispersion r̂ before and after including cell type in the GLM with NB error model

model selection analysis. Genes with higher values of 
π0 are more likely to be classified
as ZI.
Next, we fit the NB model to all genes and compared the estimated overdispersion (r̂)
with and without cell type in the GLM (Fig. 4b). Accounting for cell type consistently
reduces r̂, and the effects on different classes of ZI genes are similar to those for the 
π0
values. Thus, the overdispersion parameter of the NB model is able to identify much of
the same heterogeneity that we are capturing with the ZINB model.
Estimated zero inflation is not a reliable indicator of zero-inflated genes

The data features that distinguish the NB distribution from ZINB are subtle, and as a
result, large sample sizes are needed to identify ZI genes (Additional file 1: Fig. S2 and S4).
It seems that we could avoid the problem of mis-classification by just fitting a ZINB model
to each gene and reporting 
π0 as a quantitative estimate of zero inflation. For example, for
Ddx3y, after accounting for cell type, the estimated proportion of zero inflation is 
π0 =
0.3326. This is comparable with Xist for which 
π0 = 0.3518. These sex-specific genes
are genuinely zero-inflated (without accounting for sex), and although they are classified
differently, the 
π0 values are similar. The mis-classification of Ddx3y is due in part to its
lower overall expression level which reduces power to detect zero inflation.
In order to evaluate the utility of 
π0 as an indicator of zero inflation, we simulated NB
and ZINB data using model parameters estimated from the heart data (Simulation IV
in the “Methods” section). Then, we fit NB and ZINB models to each of the simulated
datasets. We compared estimated values to the simulated truth (Additional file 1: Fig. S8,
S9, and S10). Estimates of zero inflation from the ZINB model show a similar distribution
for both the NB and ZINB simulated data (Fig. 5a, b, and Additional file 1: Fig. S10). We
see that 
π0 can range as high as 50% for the NB simulated data, where the true value is
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Fig. 5 Estimating zero inflation with a ZINB model. Zero inflation probability 
π0 estimated by ZINB on
simulated NB data before cell type adjustment (a) and after cell type adjustment (b). Since simulated NB data
does not contain zero inflation, it is implicit that the ZINB model should produce estimates of 
π0 that are zero
or very small. However, we find substantial overestimation of this quantity for many simulated genes.
Scatterplots of true versus estimated zero inflation 
π0 by ZINB on simulated ZINB data before cell type
adjustment (c) and after cell type adjustment (d). Once cell type heterogeneity is regressed out, zero inflation
is reduced

zero. For the ZINB simulated data, 
π0 is only weakly correlated with the simulated true π0
(Fig. 5c, d). Our evaluation of 
π0 suggests that it is not a reliable indicator of zero inflation.

Discussion
Single-cell RNA sequencing data display a high frequency of zero counts. The implications of this depend on understanding the processes that give rise to zeros. Looking across
the entirety of cells in an experiment, we find that a substantial number of genes meet statistical criteria for zero inflation. However, this does not necessarily imply the existence of
an independent zero-generating process such as technical dropout. Instead, we find that
zero inflation is largely explained by biological factors, such as cell type and sex. Recent
studies of scRNA-seq in homogeneous cell populations confirm that there is no need to
invoke technical dropouts as an explanation for zeros [8, 9].
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A UMI count of zero does not necessarily imply that the gene is not expressed. This
has led some researchers to propose imputation methods that convert zeros to non-zero
values before analysis. We contend that zeros are informative data that should be incorporated directly into inferences about rates of expression and other parameters without
modification. Based on the findings in this study, we and others [8, 9, 22] recommend
against the practice of replacing zeros in data with imputed non-zero values as this could
potentially bias estimates of gene expression, reduce signatures of stochasticity, and mask
biologically relevant heterogeneity.
Model selection criteria are useful for demonstrating the presence of zero inflation, but
we recommend against using a classifier to select gene-specific models for downstream
analysis. This practice is known to result in inflated type I error rates, especially when
the power to discriminate among models is low [23, 24]. Model averaging is one possible
solution, but it can be computationally demanding and does not guarantee clear interpretation of parameters from models that we have averaged [25]. An alternative is to use a
single, robust model that leads to reasonable inferences even when mis-specified. In our
evaluation of the NB and ZINB models, the NB model produces accurate estimates of
the mean and variance of gene expression across cells, even when applied to ZINB simulated data (Additional file 1: Fig. S8 and S9). Moreover, the NB dispersion parameter (r)
is a good indicator of heterogeneity (Fig. 4b and Additional file 1: Fig. S11). There is no
perfect model, and while the ZINB model is attractive for its generality, our simulation
studies (Simulation IV ) indicate that it may not provide reliable inferences. We recommend the generalized linear model with negative binomial errors, an offset to account for
cell-to-cell variation in depth of sequencing, and including known biological factors as
explanatory variables. While there are certainly opportunities to improve aspects of the
negative binomial model [12, 21], it serves as the obvious default model for comparative
evaluation of alternative approaches and refinements.
scRATE implements a leave-one-out cross-validation (LOO-CV) method for estimating predictive accuracy [16]. One of the appealing features of the LOO-CV approach is
that it provides an estimate of the precision (the SE) of the predictive accuracy score. The
SE can be used to determine when one model is significantly better than another. This is a
distinct advantage compared to information criteria that provide only a score and rely on
rule-of-thumb criteria to discriminate among models that are effectively equivalent [26,
27]. A drawback of the LOO-CV approach is the high computational demand. In parallel
with our scRATE analysis, we computed information criterion scores. We found that AIC
and BIC provided more liberal or more conservative selection, respectively, compared to
scRATE, but this does not alter our main conclusion regarding the biological origins of
zero inflation.
In order to understand how best to utilize the SE in model selection, we used simulated
data to estimate the false negative and false positive call rates at different SE thresholds.
We determined that we could use different SE thresholds based on the type of inference
that we were making. To prove the existence of ZI genes, it is desirable to use a stringent threshold (2 SE or 3 SE). To generate a list of ZI genes with some tolerance for false
positives, we can use a more liberal threshold (1 SE).
The scRATE software provides a powerful tool to identify ZI genes in full Bayesian context, but we do not consider it to be an essential step in standard scRNA-seq workflows.
For example, the fastest way to determine that a gene is cell type-specific is to fit the NB-
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GLM model with and without cell type as a covariate and to compute the likelihood ratio
statistic. This can be done using standard GLM software R/countreg [13]. One role for
scRATE analysis would be to identify genes that, after accounting for cell type, sex, and
other known covariates, still appear to be zero-inflated. In our analysis of the heart data,
we identified a handful of genes, including multiple ribosomal subunit genes that are classified as ZI after accounting for cell type. The scRATE analysis draws our attention to
these genes and raises open questions about the possible biological explanations for zero
inflation of their count distributions.
We identified cell type as a major contributor to heterogeneity in gene expression that
can explain apparent zero inflation. Data-driven clustering is not always successful in
delineating cell subtypes and depends in part on the comparisons of interest to the analyst as well as the resolution with which data are viewed. Residual biological heterogeneity
within a particular cell type classification may reflect distinct subgroups of cells, transient cell states, or variation along a continuum. Clustering analysis divides cells into
discrete groups, but cell types are often hierarchical and distinct clusters may share different degrees of similarity [28]. Moreover, in some cases, cell “types” may exist along a
continuum [29], making cluster boundaries somewhat arbitrary and dependent on features of the clustering algorithm and data. Persistence of zero inflation or high levels of
overdispersion after accounting for cell type are indicators of unknown sources of biological variation that may prove to be useful in refining cell type hierarchies or positioning
cells along the trajectories of a continuum.
In summary, we find substantial evidence for zero inflation in scRNA-seq data, much
of which can be explained by known biological factors including cell type and sex. There
remain a number of ZI genes for which we have not identified a biological explanation.
Genes with zero inflation can potentially help to reveal hidden biological factors such
as stage in the cell cycle, activation status of immune cells, or incomplete classification
of cell types that vary across the heterogeneous mixture of cells. The model selection
procedure implemented in scRATE software provides an exploratory data analysis tool
for identifying these interesting genes.

Methods
Data

The heart data [17] consist of metabolically active, nucleated, non-myocyte cells from
heart ventricles of female and male C57BL/6J mice. The dataset was sequenced on
10X Chromium scRNA-seq platform. We used the preprocessed UMI counts (downloaded from https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6173/), originally obtained using cellranger version 1.3 (10X Genomics). Downstream analysis
using Seurat version 2.0.0 [4, 30] identified 12 cell types over 10,519 cells. In order to
ensure that we include only expressed genes in our analysis, we restricted attention to
5515 genes that had at least 1 UMI in at least 10% of cells.
Generalized linear models for count data

scRATE implements Bayesian estimation and model selection for generalized linear
models (GLMs) with or without zero inflation. The distribution of counts is modeled
using the log link function as a linear combination of an offset and covariates. The effect
of including the offset is to account for differences in total exposure (total UMI counts
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per cell). With the offset, the regression parameter estimates are scaled as rates of expression in units of UMI counts per 10,000. Including a categorical covariate, e.g., cell type,
allows the rates to vary across groups of cells. The zero-inflated models include a second component with zero inflation parameter π0 that represents the probability that an
observed datum is an obligate zero. This component uses a logistic link function and does
not require an offset. The expected number of zeros will be greater in cell types with lower
rates of expression, but the proportions of extra zeros are constant across cells. Standard
errors of estimated parameters are obtained by Monte Carlo sampling (scRATE) or by
application of the robust sandwich estimator (CountReg [13]).
Model selection

For counts associated with a given gene yc , where c is an index over cells, we fit Poisson,
negative binomial, zero-inflated Poisson, and zero-inflated negative binomial models and
evaluate their predictive accuracy based on expected log predictive density:
ELPD =

C


log p(yc |y−c ).

c=1

As a general rule, we select a model that has the largest mean ELPD as the best fit. But
the data features that distinguish the best model from other models are subtle for many
genes. The full Bayesian implementation provides an estimate of the mean and standard
error (SE) of ELPD difference between models. In case two models provide similarly good
fit, we select a simpler model unless the credible interval of ELPD margin offered by the
other (more complex) model is always positive.
Simulations
Simulation I: ZINB genes with known levels of zero inflation

We evaluated the power for detecting ZI genes by simulating ZINB data with known
zero inflation probability (π0 ) of 10, 20, 30, . . . , up to 90% based on the mean and shape
parameters estimated from the mouse heart data. We generated data with two different sequencing depths of 10,000 and 50,000 UMIs/cell. As sequencing depth increases,
we find model under-calling substantially reduces and the proportion of correct zero
inflation calls increases (Additional file 1: Fig. S2). This implies zero inflation is harder
to detect when the sequencing depth is lower. We find many studies are performed
below 10,000 UMIs/cell, for example, the median depth of coverage for the heart data
was ∼2500 UMIs/cell.
Simulation II: Simulated genes with a mix of known distributions

Using model classification and parameters estimated from the heart data, we simulated
P, NB, ZIP, and ZINB data for each of 5515 genes. We simulated data based on the 0 SE
classification by selecting distributions for genes according to the model called at 0 SE. We
repeated this process using model calls at 1 SE, 2 SE, and 3 SE. We applied scRATE model
selection with the 0, 1, 2, and 3 SE thresholds to each simulated gene set. These model calls
allow us to compute true and false positive rates for detecting ZI genes and to compute
the AUC for each combination of simulation and evaluation thresholds (Additional file 1:
Fig. S3). We find that the 1 SE threshold provides the best balance between false positive
(over-calling of model) and false negative (under-calling of model) classification.
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Simulation III: Random subsets of cells

The number of cells may have a substantial impact on the power of detecting ZI genes.
In order to assess the effect of cell number on detecting ZI genes, we generated random
subsets of cells by down-sampling data from the 10,519 cells in the mouse heart data.
The number of cells ranges from 44 up to 9000 (Additional file 1: Fig. S4). These random
subsets retain the heterogeneity of original data, and therefore, the number of ZI genes
should not appreciably change with the number of cells, except due to loss of power for
detecting ZI genes. We found that the number of ZI genes increases with the number of
cells sampled (Additional file 1: Fig. S4). This implies the number of ZI genes we detected
in the original dataset should be regarded as a lower bound.
Simulation IV: NB versus ZINB

To evaluate the effect of naïvely applying a ZINB model to non-zero-inflated data, we
simulated 5515 genes from an NB distribution with parameters estimated from the heart
data. We fit both NB and ZINB models to simulated NB data and evaluated the parameter
estimates including 
π0 for each gene. We find that fitting NB data with the ZINB model
yielded high estimates of zero inflation for many genes. Next, we simulated 5515 genes
from a ZINB distribution with parameters estimated from the heart data. We fit both NB
and ZINB models to the simulated ZINB data. ZINB is the correct model in this simulation, but we find that 
π0 estimation is still unstable for many genes (Fig. 5c, d) although
overall it has lower mean square errors than NB (Additional file 1: Table S2). We also find
that NB leads to reasonable inferences even when mis-specified in this simulation.
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